{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:22:01Z","timestamp":1740144121448,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000096","name":"National Center on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["R01MD013886-02S1"],"award-info":[{"award-number":["R01MD013886-02S1"]}],"id":[{"id":"10.13039\/100000096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s40266-022-00981-8","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T04:02:33Z","timestamp":1665979353000},"page":"875-886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antihypertensive Use and the Risk of Alzheimer\u2019s Disease and Related Dementias among Older Adults in the USA"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8705-9686","authenticated-orcid":false,"given":"Xi","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donglan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Haeng","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanhyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Dengler-Crish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry N.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devin L.","family":"Lavender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"981_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105515","volume":"166","author":"L Scotti","year":"2021","unstructured":"Scotti L, Bassi L, Soranna D, Verde F, Silani V, Torsello A, et al. Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: a meta-analysis. Pharmacol Res. 2021;166: 105515. https:\/\/doi.org\/10.1016\/j.phrs.2021.105515.","journal-title":"Pharmacol Res"},{"issue":"1","key":"981_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.archger.2010.05.021","volume":"53","author":"B Le\u00f3n-Salas","year":"2011","unstructured":"Le\u00f3n-Salas B, Olazar\u00e1n J, Mu\u00f1iz R, Gonz\u00e1lez-Salvador MT, Mart\u00ednez-Mart\u00edn P. Caregivers\u2019 estimation of patients\u2019 quality of life (QoL) in Alzheimer\u2019s disease (AD): an approach using the ADRQL. Arch Gerontol Geriatr. 2011;53(1):13\u20138. https:\/\/doi.org\/10.1016\/j.archger.2010.05.021.","journal-title":"Arch Gerontol Geriatr"},{"issue":"3","key":"981_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1017\/S1041610210001262","volume":"23","author":"AA Mougias","year":"2011","unstructured":"Mougias AA, Politis A, Lyketsos CG, Mavreas VG. Quality of life in dementia patients in Athens, Greece: predictive factors and the role of caregiver-related factors. Int Psychogeriatr. 2011;23(3):395\u2013403. https:\/\/doi.org\/10.1017\/S1041610210001262.","journal-title":"Int Psychogeriatr"},{"key":"981_CR4","doi-asserted-by":"publisher","unstructured":"Gao X, Wang K, Sun F, et al. Associates of Perceived Quality of Life in Chinese Older Adults Living with Cognitive Impairment [published online ahead of print, 2022 Jul 19]. J Gerontol Soc Work. 2022. https:\/\/doi.org\/10.1080\/01634372.2022.2103865.","DOI":"10.1080\/01634372.2022.2103865."},{"key":"981_CR5","unstructured":"The World Health Organization. Dementia, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia; 2020. Accessed 18 Apr 2021."},{"issue":"2","key":"981_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/14737175.2020.1708195","volume":"20","author":"T Lebouvier","year":"2020","unstructured":"Lebouvier T, Chen Y, Duriez P, Pasquier F, Bordet R. Antihypertensive agents in Alzheimer\u2019s disease: beyond vascular protection. Expert Rev Neurother. 2020;20(2):175\u201387.","journal-title":"Expert Rev Neurother"},{"issue":"7","key":"981_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/00325481.2019.1657776","volume":"131","author":"P Wanleenuwat","year":"2019","unstructured":"Wanleenuwat P, Iwanowski P, Kozubski W. Alzheimer\u2019s dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline. Postgrad Med. 2019;131(7):415\u201322.","journal-title":"Postgrad Med"},{"key":"981_CR8","unstructured":"Alzheimer\u2019s Association. 2021 Alzheimer\u2019s Disease Facts and Figures. Alzheimers Dement. 2021;17(3). https:\/\/www.alz.org\/media\/Documents\/alzheimers-facts-and-figures.pdf."},{"key":"981_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101612","volume":"77","author":"F Gouveia","year":"2022","unstructured":"Gouveia F, Camins A, Ettcheto M, et al. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer\u2019s disease: past, present and future. Age Res Rev. 2022;77: 101612. https:\/\/doi.org\/10.1016\/j.arr.2022.101612.","journal-title":"Age Res Rev"},{"key":"981_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JAD-190474","volume":"71","author":"MJ Lennon","year":"2019","unstructured":"Lennon MJ, Makkar SR, Crawford JD, Sachdev PS. Midlife hypertension and Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2019;71:307\u201316.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"981_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-019-0524-y","volume":"26","author":"MVF Silva","year":"2019","unstructured":"Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG. Alzheimer\u2019s disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26(1):33. https:\/\/doi.org\/10.1186\/s12929-019-0524-y.","journal-title":"J Biomed Sci"},{"issue":"24","key":"981_CR12","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1212\/WNL.0000000000004741","volume":"89","author":"ER McGrath","year":"2017","unstructured":"McGrath ER, Beiser AS, DeCarli C, et al. Blood pressure from mid- to late life and risk of incident dementia. Neurology. 2017;89(24):2447\u201354. https:\/\/doi.org\/10.1212\/WNL.0000000000004741.","journal-title":"Neurology"},{"key":"981_CR13","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3389\/fneur.2019.01020","volume":"10","author":"AM Hakim","year":"2019","unstructured":"Hakim AM. Small vessel disease. Front Neurol. 2019;10:1020.","journal-title":"Front Neurol"},{"key":"981_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86199-x","author":"K Kim","year":"2021","unstructured":"Kim K, Ji E, Choi J, et al. Ten-year trends of hypertension treatment and control rate in Korea. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-86199-x.","journal-title":"Sci Rep"},{"issue":"4","key":"981_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/ajh\/hpv122","volume":"29","author":"R Uiterwijk","year":"2016","unstructured":"Uiterwijk R, Huijts M, Staals J, et al. Endothelial activation is associated with cognitive performance in patients with hypertension. Am J Hypertens. 2016;29(4):464\u20139. https:\/\/doi.org\/10.1093\/ajh\/hpv122.","journal-title":"Am J Hypertens"},{"issue":"6","key":"981_CR16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/HYPERTENSIONAHA.115.06163","volume":"66","author":"RA Lopes","year":"2015","unstructured":"Lopes RA, Neves KB, Tostes RC, Montezano AC, Touyz RM. Downregulation of nuclear factor erythroid 2-related factor and associated antioxidant genes contributes to redox-sensitive vascular dysfunction in hypertension. Hypertension. 2015;66(6):1240\u201350. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06163.","journal-title":"Hypertension"},{"issue":"11","key":"981_CR17","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/jcbfm.2013.143","volume":"33","author":"P Toth","year":"2013","unstructured":"Toth P, Tucsek Z, Sosnowska D, et al. Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. J Cereb Blood Flow Metab. 2013;33(11):1732\u201342. https:\/\/doi.org\/10.1038\/jcbfm.2013.143.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"981_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.112.195511","volume":"60","author":"D Carnevale","year":"2012","unstructured":"Carnevale D, Mascio G, D\u2019Andrea I, et al. Hypertension induces brain \u03b2-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature. Hypertension. 2012;60(1):188\u201397. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.195511.","journal-title":"Hypertension"},{"key":"981_CR19","doi-asserted-by":"publisher","first-page":"4368474","DOI":"10.1155\/2017\/4368474","volume":"2017","author":"G Xu","year":"2017","unstructured":"Xu G, Bai F, Lin X, Wang Q, Wu Q, Sun S, et al. Association between antihypertensive drug use and the incidence of cognitive decline and dementia: a meta-analysis of prospective cohort studies. Biomed Res Int. 2017;2017:4368474. https:\/\/doi.org\/10.1155\/2017\/4368474.","journal-title":"Biomed Res Int"},{"key":"981_CR20","doi-asserted-by":"publisher","unstructured":"Lennon MJ, Lam BCP, Crawford J, Brodaty H, Kochan NA, Trollor JN, et al. Does antihypertensive use moderate the effect of blood pressure on cognitive decline in older people? J Gerontol A Biol Sci Med Sci. https:\/\/doi.org\/10.1093\/gerona\/glaa232.","DOI":"10.1093\/gerona\/glaa232"},{"issue":"3","key":"981_CR21","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","volume":"94","author":"R Peters","year":"2020","unstructured":"Peters R, Yasar S, Anderson CS, Andrews S, Antikainen R, Arima H, et al. Investigation of antihypertensive class, dementia, and cognitive decline: a meta-analysis. Neurology. 2020;94(3):e267\u201381.","journal-title":"Neurology"},{"key":"981_CR22","first-page":"3735","volume":"9","author":"SL Leong","year":"2020","unstructured":"Leong SL, Robertson IH, Lawlor B, Vanneste S. Associations between hypertension, treatment, and cognitive function in the Irish Longitudinal Study on Aging. Clin Med. 2020;9:3735.","journal-title":"Clin Med"},{"key":"981_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11906-016-0674-1","volume":"18","author":"S Yasar","year":"2016","unstructured":"Yasar S, Schuchman M, Peters J, Anstey KJ, Carlson MC, Peters R. Relationship between antihypertensive medications and cognitive impairment: Part I. Review of human studies and clinical trials. Curr Hypertens Rep. 2016;18:67. https:\/\/doi.org\/10.1007\/s11906-016-0674-1.","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"981_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1074248413501018","volume":"19","author":"NR Robles","year":"2014","unstructured":"Robles NR, Cerezo I, Hernandez-Gallego R. Renin-angiotensin system blocking drugs. J Cardiovasc Pharmacol Ther. 2014;19(1):14\u201333. https:\/\/doi.org\/10.1177\/1074248413501018.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"981_CR25","doi-asserted-by":"publisher","unstructured":"Novotny M, Klimova B, Valis M. Nitrendipine and dementia: forgotten positive facts?. Front Aging Neurosci. 2018;10:418. Published 2018 Dec 18. https:\/\/doi.org\/10.3389\/fnagi.2018.00418.","DOI":"10.3389\/fnagi.2018.00418"},{"issue":"1","key":"981_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","volume":"19","author":"J Ding","year":"2020","unstructured":"Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C, Pase MP, Himali JJ, Windham BG, Griswold M, Gottesman R. Antihypertensive medications and risk for incident dementia and Alzheimer\u2019s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol. 2020;19(1):61\u201370.","journal-title":"Lancet Neurol"},{"key":"981_CR27","unstructured":"Medical Expenditure Panel Survey, https:\/\/www.meps.ahrq.gov\/mepsweb\/about_meps\/survey_back.jsp. Accessed 22 Apr 2021."},{"issue":"1","key":"981_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/HYPERTENSIONAHA.120.15462","volume":"77","author":"J An","year":"2021","unstructured":"An J, Luong T, Qian L, Wei R, Liu R, Muntner P, Brettler J, Jaffe MG, Moran AE, Reynolds K. Treatment patterns and blood pressure control with initiation of combination versus monotherapy antihypertensive regimens. Hypertension. 2021;77(1):103\u201313.","journal-title":"Hypertension"},{"issue":"5","key":"981_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/13607863.2017.1286454","volume":"22","author":"A Deb","year":"2018","unstructured":"Deb A, Sambamoorthi U, Thornton JD, Schreus B, Innes K. Direct medical expenditures associated with Alzheimer\u2019s and related dementias (ADRD) in a nationally representative sample of older adults\u2014an excess cost approach. Aging Ment Health. 2018;22(5):619\u201324.","journal-title":"Aging Ment Health"},{"key":"981_CR30","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association, 2019 Alzheimer\u2019s disease facts and figures, Alzheimers Dement. 2019;15(3):321\u201387. https:\/\/www.alz.org\/media\/Documents\/alzheimers-facts-and-figures-2019-r.pdf pdf icon[PDF\u20131.9MB]external icon.","DOI":"10.1016\/j.jalz.2019.01.010"},{"issue":"19","key":"981_CR31","doi-asserted-by":"publisher","first-page":"15132","DOI":"10.18632\/oncotarget.23738","volume":"9","author":"MH Dai","year":"2018","unstructured":"Dai MH, Zheng H, Zeng LD, Zhang Y. The genes associated with early-onset Alzheimer\u2019s disease. Oncotarget. 2018;9(19):15132.","journal-title":"Oncotarget"},{"issue":"1","key":"981_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1212\/CON.0000000000000700","volume":"25","author":"GD Rabinovici","year":"2019","unstructured":"Rabinovici GD. Late-onset Alzheimer disease. Continuum (Minneap Minn). 2019;25(1):14\u201333. https:\/\/doi.org\/10.1212\/CON.0000000000000700.","journal-title":"Continuum (Minneap Minn)."},{"issue":"2","key":"981_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.sapharm.2019.05.002","volume":"16","author":"C Park","year":"2020","unstructured":"Park C, Wang G, Ng BP, Fang J, Durthaler JM, Ayala C. The uses and expenses of antihypertensive medications among hypertensive adults. Res Social Adm Pharm. 2020;16(2):183\u20139. https:\/\/doi.org\/10.1016\/j.sapharm.2019.05.002.","journal-title":"Res Social Adm Pharm"},{"key":"981_CR34","doi-asserted-by":"publisher","unstructured":"Wilson JR, Lorenz KA. Modeling binary correlated responses using SAS, SPSS, and R, ICSA Book Series in Statistics, vol 9. Springer, Cham; 2015, 81\u2013102. https:\/\/doi.org\/10.1007\/978-3-319-23805-0_5.","DOI":"10.1007\/978-3-319-23805-0_5"},{"key":"981_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.knosys.2014.01.012","volume":"59","author":"M Maalouf","year":"2014","unstructured":"Maalouf M, Siddiqi M. Weighted logistic regression for large-scale imbalanced and rare events data. Knowl Based Syst. 2014;59:142\u20138.","journal-title":"Knowl Based Syst"},{"issue":"10","key":"981_CR36","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1097\/HJH.0000000000000273","volume":"32","author":"R Peters","year":"2014","unstructured":"Peters R, Booth A, Peters J. A systematic review of calcium channel blocker use and cognitive decline\/dementia in the elderly. J Hypertens. 2014;32(10):1945\u201358.","journal-title":"J Hypertens"},{"issue":"2","key":"981_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","volume":"26","author":"S Yasar","year":"2005","unstructured":"Yasar S, Corrada M, Brookmeyer R, Kawas C. Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging. Neurobiol Aging. 2005;26(2):157\u201363.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"981_CR38","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1742-1241.2008.01713.x","volume":"62","author":"H Haller","year":"2008","unstructured":"Haller H. Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk. Int J Clin Pract. 2008;62(5):781\u201390. https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01713.x.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"981_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/joim.13170","volume":"289","author":"I Kalar","year":"2021","unstructured":"Kalar I, Xu H, Secnik J, et al. Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study. J Intern Med. 2021;289(4):508\u201322. https:\/\/doi.org\/10.1111\/joim.13170.","journal-title":"J Intern Med"},{"issue":"178\u201382","key":"981_CR40","volume":"13","author":"Alzheimer\u2019s Association Calcium Hypothesis Workgroup","year":"2017","unstructured":"Alzheimer\u2019s Association Calcium Hypothesis Workgroup. Calcium Hypothesis of Alzheimer\u2019s disease and brain aging: a framework for integrating new evidence into a comprehensive theory of pathogenesis. Alzheimers Dement. 2017;13(178\u201382): e17.","journal-title":"Alzheimers Dement"},{"key":"981_CR41","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrcardio.2010.161","volume":"7","author":"V Novak","year":"2010","unstructured":"Novak V, Hajjar I. The relationship between blood pressure and cognitive function. Nat Rev Cardiol. 2010;7:686\u201398.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"981_CR42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jalz.2011.05.2414","volume":"8","author":"ML Johnson","year":"2012","unstructured":"Johnson ML, Parikh N, Kunik ME, Schulz PE, Patel JG, Chen H, Aparasu RR, Morgan RO. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimers Dement. 2012;8(5):437\u201344.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"981_CR43","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1097\/HJH.0000000000001411","volume":"35","author":"T van Middelaar","year":"2017","unstructured":"van Middelaar T, van Vught LA, van Charante EPM, Eurelings LS, Ligthart SA, van Dalen JW, van den Born BJH, Richard E, van Gool WA. Lower dementia risk with different classes of antihypertensive medication in older patients. J Hypertens. 2017;35(10):2095\u2013101.","journal-title":"J Hypertens"},{"issue":"6","key":"981_CR44","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2174\/0929866527666191230103739","volume":"27","author":"VT Ribeiro","year":"2020","unstructured":"Ribeiro VT, de Souza LC, Sim\u00f5es E Silva AC. Renin-angiotensin system and Alzheimer\u2019s disease pathophysiology: from the potential interactions to therapeutic perspectives. Protein Pept Lett. 2020;27(6):484\u2013511.","journal-title":"Protein Pept Lett"},{"key":"981_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jocn.2016.02.036","volume":"33","author":"S Zhuang","year":"2016","unstructured":"Zhuang S, Wang HF, Wang X, Li J, Xing CM. The association of renin-angiotensin system blockade use with the risks of cognitive impairment of aging and Alzheimer\u2019s disease: a meta-analysis. J Clin Neurosci. 2016;33:32\u20138.","journal-title":"J Clin Neurosci"},{"key":"981_CR46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.114.04012","volume":"65","author":"SS Yoon","year":"2015","unstructured":"Yoon SS, Gu Q, Nwankwo T, Wright JD, Hong Y, Burt V. Trends in blood pressure among adults with hypertension: United States, 2003 to 2012. Hypertension. 2015;65:54\u201361.","journal-title":"Hypertension"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00981-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-022-00981-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00981-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T01:24:53Z","timestamp":1667352293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-022-00981-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["981"],"URL":"https:\/\/doi.org\/10.1007\/s40266-022-00981-8","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"type":"print","value":"1170-229X"},{"type":"electronic","value":"1179-1969"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"assertion":[{"value":"30 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors disclosed receipt of the following financial support for the research, authorship, and\/or publication of this article: This study was funded by the National Institute on Minority Health and Health Disparities (NIMHD) R01MD013886-02S1 (Principal Investigator: Donglan Zhang). The sponsor had no role or involvement other than funding. The opinions, results, and conclusions reported here are those of the authors and are independent from the funding source.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Xi Pan, Donglan Zhang, Ji Haeng Heo, Chanhyun Park, Gang Li, Christine M. Dengler-Crish, Yan Li, Yian Gu, Henry N Young, Devin L. Lavender, and Lu Shi declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/competing interests"}},{"value":"Exempt. Medical Expenditure Panel Survey (MEPS) data are publicly available to any registered user from the Agency for Healthcare Research and Quality. Collection and production of MEPS data have been reviewed and approved by the Research Triangle Institute (RTI) International Institutional Review Board (IRB), established under a multi-project assurance (Federal Assurance Number 3331) granted by the Office for Protection from Research Risks, (OPRR). The study was conducted in accordance with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Anonymized data will be shared at the reasonable request of any bona fide investigator.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}}]}}